NASDAQ:SGP | Cash Flow Statement | SpyGlass Pharma, Inc.

Complete source-backed cash-flow history.

Available history
2024-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$19.86M
2026-03-31-$13.82M-$13.54M$676,000.00-$1.67M$157.76M
2025-06-30-$8.68M
2025-03-31-$8.82M-$8.2M$164,000.00-$164,000.00$50.1M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$39.87M-$32.7M$789,000.00-$11.79M$1.45M$124.59M
2024-12-31-$29.16M-$22.03M$1.99M$22.26M$0.00$185,000.00

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.